Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124643182 | 12464318 | 2 | F | 201603 | 20160705 | 20160614 | 20160707 | EXP | US-PFIZER INC-2016296778 | PFIZER | 71.00 | YR | F | Y | 73.00000 | KG | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124643182 | 12464318 | 1 | PS | MEDROXYPROGESTERONE ACETATE. | MEDROXYPROGESTERONE ACETATE | 1 | Oral | 5 MG, DAILY | Y | 034-000048 | 11839 | 5 | MG | TABLET | |||||
| 124643182 | 12464318 | 2 | C | ESTRADIOL. | ESTRADIOL | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | ||||||
| 124643182 | 12464318 | 3 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 112 UG, 1X/DAY | 0 | 112 | UG | TABLET | QD | ||||||
| 124643182 | 12464318 | 4 | C | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | 25 MG/37.5 MG, 1X/DAY | 0 | TABLET | QD | ||||||||
| 124643182 | 12464318 | 5 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 40 MEQ, DAILY | 0 | 40 | MEQ | TABLET | |||||||
| 124643182 | 12464318 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG (1/2 TABLET), DAILY | 0 | 10 | MG | TABLET | |||||||
| 124643182 | 12464318 | 7 | C | DYTIDE | BENZTHIAZIDETRIAMTERENE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124643182 | 12464318 | 1 | Hormone replacement therapy |
| 124643182 | 12464318 | 2 | Hormone replacement therapy |
| 124643182 | 12464318 | 3 | Thyroid disorder |
| 124643182 | 12464318 | 4 | Diuretic therapy |
| 124643182 | 12464318 | 5 | Supplementation therapy |
| 124643182 | 12464318 | 6 | Blood cholesterol increased |
| 124643182 | 12464318 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124643182 | 12464318 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124643182 | 12464318 | Dizziness | |
| 124643182 | 12464318 | Loss of consciousness | |
| 124643182 | 12464318 | Malaise | |
| 124643182 | 12464318 | Palpitations | |
| 124643182 | 12464318 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124643182 | 12464318 | 1 | 201603 | 20160512 | 0 |